Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-01 Russell Angus C. Director Grant or award · Stock Option (Right to Buy) +125,000 125,000
2025-07-01 Russell Angus C. Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2024-07-01 Russell Angus C. Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-07-01 Russell Angus C. Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-07-01 Russell Angus C. Director Grant or award · Stock Option (right to buy) +50,000 50,000
2021-07-01 Russell Angus C. Director Grant or award · Stock Option (right to buy) +50,000 50,000
2021-06-29 Russell Angus C. Director Option exercise +24,720 $2.20 $54K 92,220
2021-06-29 Russell Angus C. Director Sale −4,720 $2.97 $14K 87,500
2021-06-29 Russell Angus C. Director Option exercise · Stock Option (right to buy) −24,720 0
2020-07-01 Russell Angus C. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2019-07-01 Russell Angus C. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-07-01 Russell Angus C. Director Grant or award · Option to Purchase Common Shares +40,000 40,000
2017-07-01 Russell Angus C. Director Grant or award · Option to Purchase Common Shares +20,000 20,000

Page 1 of 1 · 13 trades